Mild cognitive impairment: a treatment at last?
Allain
Hervé
H
Laboratory of Clinical and Experimental Pharmacology, Centre Mémoire Ressource Recherche de Bretagne, Faculty of Medicine University of Rennes1, France. Herve.Allain@univ-rennes1.fr
Bentué-Ferrer
Danièle
D
Akwa
Yvette
Y
D000544:Alzheimer Disease / Q000188:drug therapy / Q000201:enzymology / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D003072:Cognition Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000523:psychology; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil